Mounjaro: A New Era in Diabetes Management
Introduction Mounjaro, also known as tirzepatide, is rapidly gaining attention as a significant advancement in the treatment of type 2 diabetes. Approved by the FDA in May 2022, this medication represents a new class of diabetes treatments that mimic the action of hormones involved in blood sugar regulation. Given the soaring rates of diabetes and…